miRNA profiles in plasma from patients with sleep disorders reveal dysregulation of miRNAs in narcolepsy and other central hypersomnias

Sleep

Volumn 37, Issue 9, 2014, Pages 1525-1533

  Holm, Anja ^a   Bang Berthelsen, Claus Heiner ^a   Knudsen, Stine ^a   Kornum, Birgitte R ^a   Modvig, Signe ^a   Jennum, Poul ^a   Gammeltoft, Steen ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cataplexy; Hypersomnia; Hypocretin; miRNA; Narcolepsy

Indexed keywords

MICRORNA; NEUROPEPTIDE; OREXIN; SIGNAL PEPTIDE;

ADULT; BLOOD; CASE CONTROL STUDY; CATAPLEXY; DEFICIENCY; FEMALE; GENETICS; HUMAN; MALE; NARCOLEPSY; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SOMNOLENCE;

ADULT; CASE-CONTROL STUDIES; CATAPLEXY; FEMALE; HUMANS; HYPERSOMNOLENCE, IDIOPATHIC; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICRORNAS; NARCOLEPSY; NEUROPEPTIDES; OREXINS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 84906883236     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.4004     Document Type: Article

References (51)

1. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.
2. Young, TJ, Silber, MH. Hypersomnias of central origin. Chest 2006;130:913-20. (Pubitemid 44423630)
3. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998;50:S16-22. (Pubitemid 28100862)
4. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511. (Pubitemid 46209316)
5. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin(orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
6. Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997;20:1012-20. (Pubitemid 28042450)
7. Oka Y, Inoue Y, Kanbayashi T, et al. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings. Sleep 2006;29:1439-43. (Pubitemid 44764669)
8. Andlauer O, Moore H, Hong SC, et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep 2012;35:1247-55.
9. Anderson KN, Pilsworth S, Sharples LD, Smith IE, Shneerson JM. Idiopathic hypersomnia: a study of 77 cases. Sleep 2007;30:1274-81. (Pubitemid 47548278)
10. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136:215-33.
11. Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nat Rev Genet 2009;10:94-108.
12. McNeill E, Van Vactor D. MicroRNAs shape the neuronal landscape. Neuron 2012;75:363-79.
13. Kim J, Inoue K, Ishii J, et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007;317:1220-4.
14. Martins M, Rosa A, Guedes LC, et al. Convergence of miRNA expression profiling, a-synuclein interaction and GWAS in Parkinson's disease. PLoS One 2011;6:e25443.
15. Jin XF, Wu N, Wang L, Li J. Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell Mol Neurobiol 2013;33:601-13.
16. Cogswell J P, Ward J, Taylor IA, et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008;14:27-41. (Pubitemid 352039013)
17. Davis CJ, Bohnet SG, Meyerson JM, Krueger JM. Sleep loss changes microRNA levels in the brain: a possible mechanism for state-dependent translational regulation. Neurosci Lett 2007;422:68-73. (Pubitemid 47077578)
18. Gharib SA, Khalyfa A, Abdelkarim A, Bhushan B, Gozal D. Integrative miRNA-mRNA profiling of adipose tissue unravels transcriptional circuits induced by sleep fragmentation. PloS One 2012;7:e37669.
19. Mongrain V, Hernandez SA, Pradervand S, et al. Separating the contribution of glucocorticoids and wakefulness to the molecular and electrophysiological correlates of sleep homeostasis. Sleep 2010;33:1147-57.
20. Davis CJ, Clinton JM, Taishi P, Bohnet SG, Honn KA, Krueger JM. MicroRNA 132 alters sleep and varies with time in brain. J Appl Physiol 2011;111:665-72.
21. Davis CJ, Clinton JM, Krueger JM. MicroRNA 138, let-7b, and 125a inhibitors differentially alter sleep and EEG delta-wave activity in rats. J Appl Physiol 2012;113:1756-62.
22. Etheridge A, Gomes CP, Pereira RW, Galas D, Wang K. The complexity, function and applications of RNA in circulation. Front Genet 2013;4:115.
23. Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001;18:78-105. (Pubitemid 32549906)
24. Vernet C, Arnulf I. Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep 2009;32:753-9.
25. Knudsen S, Jennum PJ, Alving J, Sheikh SP, Gammeltoft S. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population. Sleep 2010;33:169-76.
26. Shende VR, Goldrick MM, Ramani S, Earnest DJ. Expression and rhythmic modulation of circulating microRNAs targeting the clock gene Bmal1 in mice. PLoS One 2011;6:e22586.
27. Kirschner MB, Kao SC, Edelman JJ, et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 2011;6:e24145.
28. Bergkvist A, Rusnakova V, Sindelka R, et al. Gene expression profiling-Clusters of possibilities. Methods 2010;50:323-35.
29. Mestdagh P, Van Vlierberghe P, De Weer A, et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 2009;10:R64.
30. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics 2009;25:1991-3.
31. Vlachos IS, Kostoulas N, Vergoulis T, et al. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 2012;40:W498-504.
32. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011;39,suppl 1:D152-7.
33. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular datasets. Nucleic Acids Res 2012;40:D109-14.
34. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011;29:341-5.
35. Grimaldi D, Calandra-Buonaura G, Provini F, et al. Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans. Sleep 2012;35:519-28.
36. Sorensen GL, Knudsen S, Petersen ER, et al. Attenuated heart rate response is associated with hypocretin deficiency in patients with narcolepsy. Sleep 2013;36:91-8.
37. Silvani A, Bastianini S, Berteotti C, et al. Sleep and cardiovascular phenotype in middle-aged hypocretin-deficient narcoleptic mice. J Sleep Res 2014;23:98-106.
38. Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 2012;32:12305-11.
39. Plazzi G, Parmeggiani A, Mignot E, et al. Narcolepsy-cataplexy associated with precocious puberty. Neurology 2006;66:1577-9. (Pubitemid 43958561)
40. Kok SW, Roelfsema F, Overeem S, et al. Altered setting of the pituitary-thyroid ensemble in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab 2005;288:E892-9. (Pubitemid 40547882)
41. Greco SJ, Rameshwar P. MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci U S A 2007;104:15484-9. (Pubitemid 47502943)
42. Strittmatter M, Isenberg E, Grauer MT, Hamann G, Schimrigk K. CSF substance P somatostatin and monoaminergic transmitter metabolites in patients with narcolepsy. Neurosci Lett 1996;218:99-102. (Pubitemid 26380043)
43. Jentzsch C, Leierseder S, Loyer X, et al. A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. J Mol Cell Cardiol 2012;52:13-20.
44. Caputo V, Sinibaldi L, Fiorentino A, et al. Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding. PLoS One 2011;6:e28656.
45. Klein AB, Jennum P, Knudsen S, Gammeltoft S, Mikkelsen JD. Increased serum brain-derived neurotrophic factor (BDNF) levels in patients with narcolepsy. Neurosci Lett 2013;544:31-5.
46. Cvetkovic-Lopes V, Bayer L, Dorsaz S, et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 2010;120:713-9.
47. Dobens LL Jr, Bouyain S. Developmental roles of tribbles protein family members. Dev Dyn 2012;241:1239-48.
48. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, Manjunath N. miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One 2007;2:e1020.
49. Li Z, Wu F, Brant SR, Kwon JH. IL-23 receptor regulation by Let-7f in human CD4+ memory T cells. J Immunol 2011;186:6182-90.
50. Zheng J, Jiang L, Zhang L, et al. Functional genetic variations in the IL-23 receptor gene are associated with risk of breast, lung and nasopharyngeal cancer in Chinese populations. Carcinogenesis 2012;33:2409-16.
51. Faraco J, Lin L, Kornum BR, et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet 2013;9:e1003270.